{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:34:56Z","timestamp":1764002096348,"version":"3.41.0"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T00:00:00Z","timestamp":1473379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T00:00:00Z","timestamp":1473379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01ES07331","R01ES10563","R01ES020852"],"award-info":[{"award-number":["R01ES07331","R01ES10563","R01ES020852"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s11064-016-2052-4","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T05:46:20Z","timestamp":1473399980000},"page":"1772-1786","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Disease-Toxicant Interactions in Parkinson\u2019s Disease Neuropathology"],"prefix":"10.1007","volume":"42","author":[{"given":"Gunnar F.","family":"Kwakye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael A.","family":"McMinimy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Aschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,9]]},"reference":[{"key":"2052_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2011.03.005","volume":"94","author":"H-M Gao","year":"2011","unstructured":"Gao H-M, Hong J-S (2011) Gene-environment interactions: key to unraveling the mystery of Parkinson\u2019s disease. Prog Neurobiol 94:1\u201319. doi: 10.1016\/j.pneurobio.2011.03.005","journal-title":"Prog Neurobiol"},{"key":"2052_CR2","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","volume":"54","author":"AH Schapira","year":"1990","unstructured":"Schapira AH, Cooper JM, Dexter D et al (1990) Mitochondrial complex I deficiency in Parkinson\u2019s disease. J Neurochem 54:823\u2013827","journal-title":"J Neurochem"},{"key":"2052_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/9780470572702","volume-title":"Protein misfolding diseases","author":"M Ramirez-Alvarado","year":"2010","unstructured":"Ramirez-Alvarado M, Kelly JW, Dobson CM (2010) Protein misfolding diseases. Wiley, New York. doi: 10.1002\/9780470572702"},{"key":"2052_CR4","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1056\/NEJM200012143432404","volume":"343","author":"S Sveinbj\u00f6rnsdottir","year":"2000","unstructured":"Sveinbj\u00f6rnsdottir S, Hicks AA, Jonsson T et al (2000) Familial aggregation of Parkinson\u2019s disease in Iceland. N Engl J Med 343:1765\u20131770. doi: 10.1056\/NEJM200012143432404","journal-title":"N Engl J Med"},{"key":"2052_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/ana.20228","volume":"56","author":"WA Rocca","year":"2004","unstructured":"Rocca WA, McDonnell SK, Strain KJ et al (2004) Familial aggregation of Parkinson\u2019s disease: the Mayo clinic family study. Ann Neurol 56:495\u2013502. doi: 10.1002\/ana.20228","journal-title":"Ann Neurol"},{"key":"2052_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nrg1831","volume":"7","author":"MJ Farrer","year":"2006","unstructured":"Farrer MJ (2006) Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 7:306\u2013318. doi: 10.1038\/nrg1831","journal-title":"Nat Rev Genet"},{"key":"2052_CR7","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1093\/hmg\/ddm159","volume":"2","author":"B Thomas","year":"2007","unstructured":"Thomas B, Beal MF (2007) Parkinson\u2019s disease. Hum Mol Genet 16 Spec No. 2:R183\u2013R194. doi: 10.1093\/hmg\/ddm159","journal-title":"Hum Mol Genet"},{"key":"2052_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1212\/WNL.31.1.77","volume":"31","author":"RC Duvoisin","year":"1981","unstructured":"Duvoisin RC, Eldridge R, Williams A et al (1981) Twin study of Parkinson disease. Neurology 31:77\u201380","journal-title":"Neurology"},{"key":"2052_CR9","first-page":"133","volume":"91","author":"CM Tanner","year":"2003","unstructured":"Tanner CM (2003) Is the cause of Parkinson\u2019s disease environmental or hereditary? Evidence from twin studies. Adv Neurol 91:133\u2013142","journal-title":"Adv Neurol"},{"key":"2052_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1212\/01.WNL.0000129841.30587.9D","volume":"63","author":"K Wirdefeldt","year":"2004","unstructured":"Wirdefeldt K, Gatz M, Schalling M, Pedersen NL (2004) No evidence for heritability of Parkinson disease in Swedish twins. Neurology 63:305\u2013311","journal-title":"Neurology"},{"key":"2052_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1001\/jama.281.4.341","volume":"281","author":"CM Tanner","year":"1999","unstructured":"Tanner CM, Ottman R, Goldman SM et al (1999) Parkinson disease in twins: an etiologic study. JAMA 281:341\u2013346","journal-title":"JAMA"},{"key":"2052_CR12","doi-asserted-by":"publisher","first-page":"R48","DOI":"10.1093\/hmg\/ddp012","volume":"18","author":"S Lesage","year":"2009","unstructured":"Lesage S, Brice A (2009) Parkinson\u2019s disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 18:R48\u2013R59. doi: 10.1093\/hmg\/ddp012","journal-title":"Hum Mol Genet"},{"key":"2052_CR13","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/humu.21277","volume":"31","author":"K Nuytemans","year":"2010","unstructured":"Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C (2010) Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mutat 31:763\u2013780. doi: 10.1002\/humu.21277","journal-title":"Hum Mutat"},{"key":"2052_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1750-1326-4-9","volume":"4","author":"MR Cookson","year":"2009","unstructured":"Cookson MR (2009) Alpha-synuclein and neuronal cell death. Mol Neurodegener 4:9. doi: 10.1186\/1750-1326-4-9","journal-title":"Mol Neurodegener"},{"key":"2052_CR15","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba M, Nakajo S, Tu PH et al (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am J Pathol 152:879\u2013884","journal-title":"Am J Pathol"},{"key":"2052_CR16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/embor.2010.66","volume":"11","author":"F Darios","year":"2010","unstructured":"Darios F, Ruip\u00e9rez V, L\u00f3pez I et al (2010) Alpha-synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosis. EMBO Rep 11:528\u2013533. doi: 10.1038\/embor.2010.66","journal-title":"EMBO Rep"},{"key":"2052_CR17","doi-asserted-by":"publisher","first-page":"41958","DOI":"10.1074\/jbc.M105022200","volume":"276","author":"RJ Perrin","year":"2001","unstructured":"Perrin RJ, Woods WS, Clayton DF, George JM (2001) Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins. J Biol Chem 276:41958\u201341962. doi: 10.1074\/jbc.M105022200","journal-title":"J Biol Chem"},{"key":"2052_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","volume":"37","author":"R Sharon","year":"2003","unstructured":"Sharon R, Bar-Joseph I, Frosch MP et al (2003) The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson\u2019s disease. Neuron 37:583\u2013595","journal-title":"Neuron"},{"key":"2052_CR19","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.2353\/ajpath.2007.070373","volume":"171","author":"K Assayag","year":"2007","unstructured":"Assayag K, Yakunin E, Loeb V et al (2007) Polyunsaturated fatty acids induce alpha-synuclein-related pathogenic changes in neuronal cells. Am J Pathol 171:2000\u20132011. doi: 10.2353\/ajpath.2007.070373","journal-title":"Am J Pathol"},{"key":"2052_CR20","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) \u03b1-Synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a009399. doi: 10.1101\/cshperspect.a009399","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2052_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels T, Choi JG, Selkoe DJ (2011) \u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477:107\u2013110. doi: 10.1038\/nature10324","journal-title":"Nature"},{"key":"2052_CR22","doi-asserted-by":"publisher","first-page":"24065","DOI":"10.1074\/jbc.M002413200","volume":"275","author":"CA da Costa","year":"2000","unstructured":"da Costa CA, Ancolio K, Checler F (2000) Wild-type but not Parkinson\u2019s disease-related ala-53 \u2192 Thr mutant alpha-synuclein protects neuronal cells from apoptotic stimuli. J Biol Chem 275:24065\u201324069. doi: 10.1074\/jbc.M002413200","journal-title":"J Biol Chem"},{"key":"2052_CR23","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1046\/j.1471-4159.2003.01835.x","volume":"86","author":"PJ Jensen","year":"2003","unstructured":"Jensen PJ, Alter BJ, O\u2019Malley KL (2003) Alpha-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity. J Neurochem 86:196\u2013209","journal-title":"J Neurochem"},{"key":"2052_CR24","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1093\/brain\/awu057","volume":"137","author":"E Rockenstein","year":"2014","unstructured":"Rockenstein E, Nuber S, Overk CR et al (2014) Accumulation of oligomer-prone \u03b1-synuclein exacerbates synaptic and neuronal degeneration in vivo. Brain 137:1496\u20131513. doi: 10.1093\/brain\/awu057","journal-title":"Brain"},{"issue":"3","key":"2052_CR25","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1002\/ana.10512","volume":"53","author":"KSP McNaught","year":"2003","unstructured":"McNaught KSP, Olanow CW (2003) Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson\u2019s disease. Ann Neurol 53 Suppl 3:S73\u201384. doi: 10.1002\/ana.10512 (discussion S84)","journal-title":"Ann Neurol"},{"key":"2052_CR26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"J-Y Li","year":"2008","unstructured":"Li J-Y, Englund E, Holton JL et al (2008) Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat Med 14:501\u2013503. doi: 10.1038\/nm1746","journal-title":"Nat Med"},{"key":"2052_CR27","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA et al (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat Med 14:504\u2013506. doi: 10.1038\/nm1747","journal-title":"Nat Med"},{"key":"2052_CR28","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","volume":"25","author":"H-J Lee","year":"2005","unstructured":"Lee H-J, Patel S, Lee S-J (2005) Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci 25:6016\u20136024. doi: 10.1523\/JNEUROSCI.0692-05.2005","journal-title":"J Neurosci"},{"key":"2052_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1074\/jbc.M107045200","volume":"277","author":"H-J Lee","year":"2002","unstructured":"Lee H-J, Choi C, Lee S-J (2002) Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J Biol Chem 277:671\u2013678. doi: 10.1074\/jbc.M107045200","journal-title":"J Biol Chem"},{"key":"2052_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0896-6273(95)90040-3","volume":"15","author":"JM George","year":"1995","unstructured":"George JM, Jin H, Woods WS, Clayton DF (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15:361\u2013372","journal-title":"Neuron"},{"key":"2052_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0304-3940(00)01153-8","volume":"287","author":"R Borghi","year":"2000","unstructured":"Borghi R, Marchese R, Negro A et al (2000) Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson\u2019s disease and normal subjects. Neurosci Lett 287:65\u201367. doi: 10.1016\/S0304-3940(00)01153-8","journal-title":"Neurosci Lett"},{"key":"2052_CR32","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1096\/fj.03-0098fje","volume":"17","author":"OMA El-Agnaf","year":"2003","unstructured":"El-Agnaf OMA, Salem SA, Paleologou KE et al (2003) Alpha-synuclein implicated in Parkinson\u2019s disease is present in extracellular biological fluids, including human plasma. FASEB J 17:1945\u20131947. doi: 10.1096\/fj.03-0098fje","journal-title":"FASEB J"},{"key":"2052_CR33","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1212\/01.WNL.0000127517.33208.F4","volume":"62","author":"DW Miller","year":"2004","unstructured":"Miller DW, Hague SM, Clarimon J et al (2004) Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology 62:1835\u20131838","journal-title":"Neurology"},{"key":"2052_CR34","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats P, Lee H-J, Bae E-J et al (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 106:13010\u201313015. doi: 10.1073\/pnas.0903691106","journal-title":"Proc Natl Acad Sci USA"},{"key":"2052_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"KM Danzer","year":"2012","unstructured":"Danzer KM, Kranich LR, Ruf WP, et al (2012) Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener 7:42. doi: 10.1186\/1750-1326-7-42","journal-title":"Mol Neurodegener"},{"key":"2052_CR36","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","volume":"42","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Schapira AH et al (2011) Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis 42:360\u2013367. doi: 10.1016\/j.nbd.2011.01.029","journal-title":"Neurobiol Dis"},{"key":"2052_CR37","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Melachroinou K, Roumeliotis T et al (2010) Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30:6838\u20136851. doi: 10.1523\/JNEUROSCI.5699-09.2010","journal-title":"J Neurosci"},{"key":"2052_CR38","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","volume":"22","author":"RG Perez","year":"2002","unstructured":"Perez RG, Waymire JC, Lin E et al (2002) A role for alpha-synuclein in the regulation of dopamine biosynthesis. J Neurosci 22:3090\u20133099","journal-title":"J Neurosci"},{"key":"2052_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neulet.2008.02.014","volume":"435","author":"TNM Alerte","year":"2008","unstructured":"Alerte TNM, Akinfolarin AA, Friedrich EE et al (2008) Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice. Neurosci Lett 435:24\u201329. doi: 10.1016\/j.neulet.2008.02.014","journal-title":"Neurosci Lett"},{"key":"2052_CR40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1006\/nbdi.2000.0319","volume":"7","author":"Y Zhang","year":"2000","unstructured":"Zhang Y, Dawson VL, Dawson TM (2000) Oxidative stress and genetics in the pathogenesis of Parkinson\u2019s disease. Neurobiol Dis 7:240\u2013250. doi: 10.1006\/nbdi.2000.0319","journal-title":"Neurobiol Dis"},{"key":"2052_CR41","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1073\/pnas.97.2.571","volume":"97","author":"KA Conway","year":"2000","unstructured":"Conway KA, Lee SJ, Rochet JC et al (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy. Proc Natl Acad Sci USA 97:571\u2013576","journal-title":"Proc Natl Acad Sci USA"},{"key":"2052_CR42","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1038\/emboj.2009.257","volume":"28","author":"DP Karpinar","year":"2009","unstructured":"Karpinar DP, Balija MBG, K\u00fcgler S et al (2009) Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson\u2019s disease models. EMBO J 28:3256\u20133268. doi: 10.1038\/emboj.2009.257","journal-title":"EMBO J"},{"key":"2052_CR43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4","volume":"61","author":"JE Duda","year":"2000","unstructured":"Duda JE, Lee VM, Trojanowski JQ (2000) Neuropathology of synuclein aggregates. J Neurosci Res 61:121\u2013127","journal-title":"J Neurosci Res"},{"key":"2052_CR44","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/ana.22078","volume":"67","author":"K Seidel","year":"2010","unstructured":"Seidel K, Sch\u00f6ls L, Nuber S et al (2010) First appraisal of brain pathology owing to A30P mutant alpha-synuclein. Ann Neurol 67:684\u2013689. doi: 10.1002\/ana.21966","journal-title":"Ann Neurol"},{"key":"2052_CR45","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"M-C Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin M-C, Kachergus J, Roumier C et al (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet 364:1167\u20131169. doi: 10.1016\/S0140-6736(04)17103-1","journal-title":"Lancet"},{"key":"2052_CR46","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.20753","volume":"59","author":"K Nishioka","year":"2006","unstructured":"Nishioka K, Hayashi S, Farrer MJ et al (2006) Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson\u2019s disease. Ann Neurol 59:298\u2013309. doi: 10.1002\/ana.20753","journal-title":"Ann Neurol"},{"key":"2052_CR47","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/jama.296.6.661","volume":"296","author":"DM Maraganore","year":"2006","unstructured":"Maraganore DM, de Andrade M, Elbaz A et al (2006) Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 296:661\u2013670. doi: 10.1001\/jama.296.6.661","journal-title":"JAMA"},{"key":"2052_CR48","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/mds.22051","volume":"23","author":"MG Cersosimo","year":"2008","unstructured":"Cersosimo MG, Benarroch EE (2008) Neural control of the gastrointestinal tract: implications for Parkinson disease. Mov Disord 23:1065\u20131075. doi: 10.1002\/mds.22051","journal-title":"Mov Disord"},{"key":"2052_CR49","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U et al (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"2052_CR50","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1093\/hmg\/10.17.1847","volume":"10","author":"M Farrer","year":"2001","unstructured":"Farrer M, Maraganore DM, Lockhart P et al (2001) Alpha-synuclein gene haplotypes are associated with Parkinson\u2019s disease. Hum Mol Genet 10:1847\u20131851","journal-title":"Hum Mol Genet"},{"key":"2052_CR51","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.parkreldis.2013.02.008","volume":"19","author":"SJ Chung","year":"2013","unstructured":"Chung SJ, Armasu SM, Anderson KJ et al (2013) Genetic susceptibility loci, environmental exposures, and Parkinson\u2019s disease: a case-control study of gene-environment interactions. Parkinsonism Relat Disord 19:595\u2013599. doi: 10.1016\/j.parkreldis.2013.02.008","journal-title":"Parkinsonism Relat Disord"},{"key":"2052_CR52","doi-asserted-by":"publisher","first-page":"9879","DOI":"10.1073\/pnas.1004676107","volume":"107","author":"Y Tong","year":"2010","unstructured":"Tong Y, Yamaguchi H, Giaime E et al (2010) Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice. Proc Natl Acad Sci USA 107:9879\u20139884. doi: 10.1073\/pnas.1004676107","journal-title":"Proc Natl Acad Sci USA"},{"key":"2052_CR53","doi-asserted-by":"publisher","first-page":"18676","DOI":"10.1073\/pnas.0508052102","volume":"102","author":"WW Smith","year":"2005","unstructured":"Smith WW, Pei Z, Jiang H et al (2005) Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc Natl Acad Sci USA 102:18676\u201318681. doi: 10.1073\/pnas.0508052102","journal-title":"Proc Natl Acad Sci USA"},{"key":"2052_CR54","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.nbd.2008.06.016","volume":"32","author":"AKF Liou","year":"2008","unstructured":"Liou AKF, Leak RK, Li L, Zigmond MJ (2008) Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway. Neurobiol Dis 32:116\u2013124. doi: 10.1016\/j.nbd.2008.06.016","journal-title":"Neurobiol Dis"},{"key":"2052_CR55","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy DG, Falchi M, O\u2019Sullivan SS et al (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study. Lancet Neurol 7:583\u2013590. doi: 10.1016\/S1474-4422(08)70117-0","journal-title":"Lancet Neurol"},{"issue":"3","key":"2052_CR56","doi-asserted-by":"publisher","first-page":"S309","DOI":"10.1016\/S1353-8020(08)70022-1","volume":"13","author":"CA Ross","year":"2007","unstructured":"Ross CA, Smith WW (2007) Gene-environment interactions in Parkinson\u2019s disease. Parkinsonism Relat Disord 13(Suppl 3):S309\u2013S315. doi: 10.1016\/S1353-8020(08)70022-1","journal-title":"Parkinsonism Relat Disord"},{"key":"2052_CR57","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1469-1809.2009.00524.x","volume":"73","author":"C Pais\u00e1n-Ruiz","year":"2009","unstructured":"Pais\u00e1n-Ruiz C, Washecka N, Nath P et al (2009) Parkinson\u2019s disease and low frequency alleles found together throughout LRRK2. Ann Hum Genet 73:391\u2013403. doi: 10.1111\/j.1469-1809.2009.00524.x","journal-title":"Ann Hum Genet"},{"key":"2052_CR58","doi-asserted-by":"publisher","first-page":"9210","DOI":"10.1523\/JNEUROSCI.2281-09.2009","volume":"29","author":"S Saha","year":"2009","unstructured":"Saha S, Guillily MD, Ferree A et al (2009) LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans. J Neurosci 29:9210\u20139218. doi: 10.1523\/JNEUROSCI.2281-09.2009","journal-title":"J Neurosci"},{"key":"2052_CR59","doi-asserted-by":"publisher","first-page":"11257","DOI":"10.1523\/JNEUROSCI.2375-09.2009","volume":"29","author":"C-H Ng","year":"2009","unstructured":"Ng C-H, Mok SZS, Koh C et al (2009) Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila. J Neurosci 29:11257\u201311262. doi: 10.1523\/JNEUROSCI.2375-09.2009","journal-title":"J Neurosci"},{"key":"2052_CR60","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.12.003","volume":"22","author":"R Betarbet","year":"2006","unstructured":"Betarbet R, Canet-Aviles RM, Sherer TB et al (2006) Intersecting pathways to neurodegeneration in Parkinson\u2019s disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system. Neurobiol Dis 22:404\u2013420. doi: 10.1016\/j.nbd.2005.12.003","journal-title":"Neurobiol Dis"},{"key":"2052_CR61","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1083\/jcb.200809125","volume":"183","author":"D Narendra","year":"2008","unstructured":"Narendra D, Tanaka A, Suen D-F, Youle RJ (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183:795\u2013803. doi: 10.1083\/jcb.200809125","journal-title":"J Cell Biol"},{"issue":"1","key":"2052_CR62","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1186\/1471-2091-8-S1-S13","volume":"8","author":"K-L Lim","year":"2007","unstructured":"Lim K-L, Tan JMM (2007) Role of the ubiquitin proteasome system in Parkinson\u2019s disease. BMC Biochem 8(Suppl 1):S13. doi: 10.1186\/1471-2091-8-S1-S13","journal-title":"BMC Biochem"},{"key":"2052_CR63","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1073\/pnas.0737556100","volume":"100","author":"JC Greene","year":"2003","unstructured":"Greene JC, Whitworth AJ, Kuo I et al (2003) Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA 100:4078\u20134083. doi: 10.1073\/pnas.0737556100","journal-title":"Proc Natl Acad Sci USA"},{"key":"2052_CR64","doi-asserted-by":"publisher","first-page":"8024","DOI":"10.1073\/pnas.0501078102","volume":"102","author":"AJ Whitworth","year":"2005","unstructured":"Whitworth AJ, Theodore DA, Greene JC et al (2005) Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 102:8024\u20138029. doi: 10.1073\/pnas.0501078102","journal-title":"Proc Natl Acad Sci USA"},{"key":"2052_CR65","doi-asserted-by":"publisher","first-page":"18614","DOI":"10.1074\/jbc.M401135200","volume":"279","author":"JJ Palacino","year":"2004","unstructured":"Palacino JJ, Sagi D, Goldberg MS et al (2004) Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem 279:18614\u201318622. doi: 10.1074\/jbc.M401135200","journal-title":"J Biol Chem"},{"key":"2052_CR66","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1073\/pnas.0709336105","volume":"105","author":"AC Poole","year":"2008","unstructured":"Poole AC, Thomas RE, Andrews LA et al (2008) The PINK1\/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci USA 105:1638\u20131643. doi: 10.1073\/pnas.0709336105","journal-title":"Proc Natl Acad Sci USA"},{"key":"2052_CR67","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1212\/WNL.46.5.1275","volume":"46","author":"A Seidler","year":"1996","unstructured":"Seidler A, Hellenbrand W, Robra BP et al (1996) Possible environmental, occupational, and other etiologic factors for Parkinson\u2019s disease: a case-control study in Germany. Neurology 46:1275\u20131284","journal-title":"Neurology"},{"key":"2052_CR68","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12017-009-8083-0","volume":"11","author":"M Aschner","year":"2009","unstructured":"Aschner M, Erikson KM, Herrero Hern\u00e1ndez E et al (2009) Manganese and its role in Parkinson\u2019s disease: from transport to neuropathology. Neuromolecular Med 11:252\u2013266. doi: 10.1007\/s12017-009-8083-0","journal-title":"Neuromolecular Med"},{"key":"2052_CR69","doi-asserted-by":"publisher","first-page":"7519","DOI":"10.3390\/ijerph120707519","volume":"12","author":"GF Kwakye","year":"2015","unstructured":"Kwakye GF, Paoliello MMB, Mukhopadhyay S et al (2015) Manganese-induced parkinsonism and parkinson\u2019s disease: shared and distinguishable features. Int J Environ Res Public Health 12:7519\u20137540. doi: 10.3390\/ijerph120707519","journal-title":"Int J Environ Res Public Health"},{"key":"2052_CR70","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0165-0173(02)00234-5","volume":"41","author":"A Takeda","year":"2003","unstructured":"Takeda A (2003) Manganese action in brain function. Brain Res Brain Res Rev 41:79\u201387","journal-title":"Brain Res Brain Res Rev"},{"key":"2052_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408440590905920","volume":"35","author":"M Aschner","year":"2005","unstructured":"Aschner M, Erikson KM, Dorman DC (2005) Manganese dosimetry: species differences and implications for neurotoxicity. Crit Rev Toxicol 35:1\u201332","journal-title":"Crit Rev Toxicol"},{"key":"2052_CR72","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/nen.0b013e31812503cf","volume":"66","author":"DP Perl","year":"2007","unstructured":"Perl DP, Olanow CW (2007) The neuropathology of manganese-induced Parkinsonism. J Neuropathol Exp Neurol 66:675\u2013682. doi: 10.1097\/nen.0b013e31812503cf","journal-title":"J Neuropathol Exp Neurol"},{"key":"2052_CR73","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.etap.2004.12.053","volume":"19","author":"KM Erikson","year":"2005","unstructured":"Erikson KM, Syversen T, Aschner JL, Aschner M (2005) Interactions between excessive manganese exposures and dietary iron-deficiency in neurodegeneration. Environ Toxicol Pharmacol 19:415\u2013421. doi: 10.1016\/j.etap.2004.12.053","journal-title":"Environ Toxicol Pharmacol"},{"key":"2052_CR74","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1196\/annals.1306.009","volume":"1012","author":"AW Dobson","year":"2004","unstructured":"Dobson AW, Erikson KM, Aschner M (2004) Manganese neurotoxicity. Ann N Y Acad Sci 1012:115\u2013128","journal-title":"Ann N Y Acad Sci"},{"key":"2052_CR75","first-page":"89","volume":"37","author":"CL Keen","year":"2000","unstructured":"Keen CL, Ensunsa JL, Clegg MS (2000) Manganese metabolism in animals and humans including the toxicity of manganese. Met Ions Biol Syst 37:89\u2013121","journal-title":"Met Ions Biol Syst"},{"key":"2052_CR76","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1159\/000026225","volume":"18","author":"JM Gorell","year":"1999","unstructured":"Gorell JM, Rybicki BA, Cole Johnson C, Peterson EL (1999) Occupational metal exposures and the risk of Parkinson\u2019s disease. Neuroepidemiology 18:303\u2013308","journal-title":"Neuroepidemiology"},{"key":"2052_CR77","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jtemb.2011.08.144","volume":"25","author":"AB Bowman","year":"2011","unstructured":"Bowman AB, Kwakye GF, Herrero Hern\u00e1ndez E, Aschner M (2011) Role of manganese in neurodegenerative diseases. J Trace Elem Med Biol 25:191\u2013203. doi: 10.1016\/j.jtemb.2011.08.144","journal-title":"J Trace Elem Med Biol"},{"key":"2052_CR78","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1177\/0148607199023006333","volume":"23","author":"K Fitzgerald","year":"1999","unstructured":"Fitzgerald K, Mikalunas V, Rubin H et al (1999) Hypermanganesemia in patients receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr 23:333\u2013336","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2052_CR79","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/0148607100024004223","volume":"24","author":"DB Bertinet","year":"2000","unstructured":"Bertinet DB, Tinivella M, Balzola FA et al (2000) Brain manganese deposition and blood levels in patients undergoing home parenteral nutrition. JPEN J Parenter Enteral Nutr 24:223\u2013227","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2052_CR80","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/ana.410360611","volume":"36","author":"RA Hauser","year":"1994","unstructured":"Hauser RA, Zesiewicz TA, Rosemurgy AS et al (1994) Manganese intoxication and chronic liver failure. Ann Neurol 36:871\u2013875. doi: 10.1002\/ana.410360611","journal-title":"Ann Neurol"},{"key":"2052_CR81","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1752-1947-5-146","volume":"5","author":"WM Verhoeven","year":"2011","unstructured":"Verhoeven WM, Egger JI, Kuijpers HJ (2011) Manganese and acute paranoid psychosis: a case report. J Med Case Reports 5:146. doi: 10.1186\/1752-1947-5-146","journal-title":"J Med Case Reports"},{"key":"2052_CR82","first-page":"227","volume":"20","author":"PK Pal","year":"1999","unstructured":"Pal PK, Samii A, Calne DB (1999) Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology 20:227\u2013238","journal-title":"Neurotoxicology"},{"key":"2052_CR83","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/mds.10089","volume":"17","author":"Y Kim","year":"2002","unstructured":"Kim Y, Kim JM, Kim JW et al (2002) Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean? Mov Disord 17:568\u2013575. doi: 10.1002\/mds.10089","journal-title":"Mov Disord"},{"key":"2052_CR84","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/ajim.20489","volume":"50","author":"MF Struve","year":"2007","unstructured":"Struve MF, McManus BE, Wong BA, Dorman DC (2007) Basal ganglia neurotransmitter concentrations in rhesus monkeys following subchronic manganese sulfate inhalation. Am J Ind Med 50:772\u2013778. doi: 10.1002\/ajim.20489","journal-title":"Am J Ind Med"},{"key":"2052_CR85","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ng.300","volume":"41","author":"AD Gitler","year":"2009","unstructured":"Gitler AD, Chesi A, Geddie ML et al (2009) Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet 41:308\u2013315. doi: 10.1038\/ng.300","journal-title":"Nat Genet"},{"key":"2052_CR86","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.neuro.2009.02.005","volume":"30","author":"DM Cowan","year":"2009","unstructured":"Cowan DM, Zheng W, Zou Y et al (2009) Manganese exposure among smelting workers: relationship between blood manganese-iron ratio and early onset neurobehavioral alterations. Neurotoxicology 30:1214\u20131222. doi: 10.1016\/j.neuro.2009.02.005","journal-title":"Neurotoxicology"},{"key":"2052_CR87","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0361-9230(01)00456-7","volume":"55","author":"EA Malecki","year":"2001","unstructured":"Malecki EA (2001) Manganese toxicity is associated with mitochondrial dysfunction and DNA fragmentation in rat primary striatal neurons. Brain Res Bull 55:225\u2013228","journal-title":"Brain Res Bull"},{"key":"2052_CR88","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.tox.2013.01.006","volume":"305","author":"B Xu","year":"2013","unstructured":"Xu B, Wu S-W, Lu C-W et al (2013) Oxidative stress involvement in manganese-induced alpha-synuclein oligomerization in organotypic brain slice cultures. Toxicology 305:71\u201378. doi: 10.1016\/j.tox.2013.01.006","journal-title":"Toxicology"},{"key":"2052_CR89","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","volume":"157","author":"LJ Hsu","year":"2000","unstructured":"Hsu LJ, Sagara Y, Arroyo A et al (2000) Alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 157:401\u2013410","journal-title":"Am J Pathol"},{"key":"2052_CR90","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1046\/j.1471-4159.1999.0731155.x","volume":"73","author":"R Migheli","year":"1999","unstructured":"Migheli R, Godani C, Sciola L et al (1999) Enhancing effect of manganese on L-DOPA-induced apoptosis in PC12 cells: role of oxidative stress. J Neurochem 73:1155\u20131163","journal-title":"J Neurochem"},{"key":"2052_CR91","first-page":"445","volume":"20","author":"CE Gavin","year":"1999","unstructured":"Gavin CE, Gunter KK, Gunter TE (1999) Manganese and calcium transport in mitochondria: implications for manganese toxicity. Neurotoxicology 20:445\u2013453","journal-title":"Neurotoxicology"},{"key":"2052_CR92","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3109\/15376516.2011.560210","volume":"21","author":"K Prabhakaran","year":"2011","unstructured":"Prabhakaran K, Chapman GD, Gunasekar PG (2011) \u03b1-Synuclein overexpression enhances manganese-induced neurotoxicity through the NF-\u03baB-mediated pathway. Toxicol Mech Methods 21:435\u2013443. doi: 10.3109\/15376516.2011.560210","journal-title":"Toxicol Mech Methods"},{"key":"2052_CR93","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.brainres.2010.08.055","volume":"1359","author":"T Cai","year":"2010","unstructured":"Cai T, Yao T, Zheng G et al (2010) Manganese induces the overexpression of \u03b1-synuclein in PC12 cells via ERK activation. Brain Res 1359:201\u2013207. doi: 10.1016\/j.brainres.2010.08.055","journal-title":"Brain Res"},{"key":"2052_CR94","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/toxsci\/kfu247","volume":"143","author":"DS Harischandra","year":"2015","unstructured":"Harischandra DS, Jin H, Anantharam V et al (2015) \u03b1-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson\u2019s disease. Toxicol Sci 143:454\u2013468. doi: 10.1093\/toxsci\/kfu247","journal-title":"Toxicol Sci"},{"key":"2052_CR95","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1039\/C3MT00325F","volume":"6","author":"J Bornhorst","year":"2014","unstructured":"Bornhorst J, Chakraborty S, Meyer S et al (2014) The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of \u03b1-synuclein in C. elegans. Metallomics 6:476\u2013490. doi: 10.1039\/c3mt00325f","journal-title":"Metallomics"},{"key":"2052_CR96","doi-asserted-by":"publisher","first-page":"44284","DOI":"10.1074\/jbc.M105343200","volume":"276","author":"VN Uversky","year":"2001","unstructured":"Uversky VN, Li J, Fink AL (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson\u2019s disease and heavy metal exposure. J Biol Chem 276:44284\u201344296. doi: 10.1074\/jbc.M105343200","journal-title":"J Biol Chem"},{"key":"2052_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005072-196801000-00001","volume":"27","author":"KM Earle","year":"1968","unstructured":"Earle KM (1968) Studies on Parkinson\u2019s disease including X-ray fluorescent spectroscopy of formalin fixed brain tissue. J Neuropathol Exp Neurol 27:1\u201314","journal-title":"J Neuropathol Exp Neurol"},{"key":"2052_CR98","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF01244786","volume":"74","author":"E Sofic","year":"1988","unstructured":"Sofic E, Riederer P, Heinsen H et al (1988) Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm 74:199\u2013205","journal-title":"J Neural Transm"},{"issue":"4","key":"2052_CR99","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","volume":"114","author":"DT Dexter","year":"1991","unstructured":"Dexter DT, Carayon A, Javoy-Agid F et al (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114(Pt 4):1953\u20131975","journal-title":"Brain"},{"key":"2052_CR100","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0161-813X(02)00099-2","volume":"23","author":"DA Di Monte","year":"2002","unstructured":"Di Monte DA, Lavasani M, Manning-Bog AB (2002) Environmental factors in Parkinson\u2019s disease. Neurotoxicology 23:487\u2013502","journal-title":"Neurotoxicology"},{"key":"2052_CR101","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/aje\/kwq303","volume":"172","author":"AW Willis","year":"2010","unstructured":"Willis AW, Evanoff BA, Lian M et al (2010) Metal emissions and urban incident Parkinson disease: a community health study of Medicare beneficiaries by using geographic information systems. Am J Epidemiol 172:1357\u20131363. doi: 10.1093\/aje\/kwq303","journal-title":"Am J Epidemiol"},{"key":"2052_CR102","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979\u2013980","journal-title":"Science"},{"key":"2052_CR103","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1212\/WNL.35.7.949","volume":"35","author":"Ballard PA","year":"1985","unstructured":"Ballard PA, Tetrud JW, Langston JW (1985) Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 35:949\u2013956","journal-title":"Neurology"},{"key":"2052_CR104","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","volume":"46","author":"JW Langston","year":"1999","unstructured":"Langston JW, Forno LS, Tetrud J et al (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46:598\u2013605","journal-title":"Ann Neurol"},{"key":"2052_CR105","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1016\/S0021-9258(18)60674-X","volume":"263","author":"AJ Daniels","year":"1988","unstructured":"Daniels AJ, Reinhard JF (1988) Energy-driven uptake of the neurotoxin 1-methyl-4-phenylpyridinium into chromaffin granules via the catecholamine transporter. J Biol Chem 263:5034\u20135036","journal-title":"J Biol Chem"},{"key":"2052_CR106","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1046\/j.1471-4159.1997.69031322.x","volume":"69","author":"RR Gainetdinov","year":"1997","unstructured":"Gainetdinov RR, Fumagalli F, Jones SR, Caron MG (1997) Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter. J Neurochem 69:1322\u20131325","journal-title":"J Neurochem"},{"key":"2052_CR107","doi-asserted-by":"publisher","first-page":"9938","DOI":"10.1073\/pnas.94.18.9938","volume":"94","author":"N Takahashi","year":"1997","unstructured":"Takahashi N, Miner LL, Sora I et al (1997) VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc Natl Acad Sci USA 94:9938\u20139943","journal-title":"Proc Natl Acad Sci USA"},{"key":"2052_CR108","first-page":"309","volume":"292","author":"A Vaccari","year":"1995","unstructured":"Vaccari A, Saba P (1995) The tyramine-labelled vesicular transporter for dopamine: a putative target of pesticides and neurotoxins. Eur J Pharmacol 292:309\u2013314","journal-title":"Eur J Pharmacol"},{"key":"2052_CR109","first-page":"631","volume":"20","author":"GW Miller","year":"1999","unstructured":"Miller GW, Kirby ML, Levey AI, Bloomquist JR (1999) Heptachlor alters expression and function of dopamine transporters. Neurotoxicology 20:631\u2013637","journal-title":"Neurotoxicology"},{"key":"2052_CR110","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0026-895X(25)13535-9","volume":"14","author":"DG Graham","year":"1978","unstructured":"Graham DG (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 14:633\u2013643","journal-title":"Mol Pharmacol"},{"key":"2052_CR111","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/70978","volume":"5","author":"GT Liberatore","year":"1999","unstructured":"Liberatore GT, Jackson-Lewis V, Vukosavic S et al (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 5:1403\u20131409. doi: 10.1038\/70978","journal-title":"Nat Med"},{"key":"2052_CR112","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","volume":"39","author":"LJ Lawson","year":"1990","unstructured":"Lawson LJ, Perry VH, Dri P, Gordon S (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39:151\u2013170","journal-title":"Neuroscience"},{"key":"2052_CR113","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","volume":"60","author":"H Chen","year":"2003","unstructured":"Chen H, Zhang SM, Hern\u00e1n MA et al (2003) Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol 60:1059\u20131064. doi: 10.1001\/archneur.60.8.1059","journal-title":"Arch Neurol"},{"key":"2052_CR114","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0024-3205(88)90115-4","volume":"43","author":"Y Makino","year":"1988","unstructured":"Makino Y, Ohta S, Tachikawa O, Hirobe M (1988) Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: compounds related to Parkinson\u2019s disease. Life Sci 43:373\u2013378","journal-title":"Life Sci"},{"key":"2052_CR115","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0006-8993(95)00082-2","volume":"675","author":"EJ Neafsey","year":"1995","unstructured":"Neafsey EJ, Albores R, Gearhart D et al (1995) Methyl-beta-carbolinium analogs of MPP + cause nigrostriatal toxicity after substantia nigra injections in rats. Brain Res 675:279\u2013288","journal-title":"Brain Res"},{"key":"2052_CR116","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.nbd.2005.05.028","volume":"20","author":"MG Purisai","year":"2005","unstructured":"Purisai MG, McCormack AL, Langston WJ et al (2005) Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates. Neurobiol Dis 20:898\u2013906. doi: 10.1016\/j.nbd.2005.05.028","journal-title":"Neurobiol Dis"},{"key":"2052_CR117","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/syn.20089","volume":"55","author":"Z Xu","year":"2005","unstructured":"Xu Z, Cawthon D, McCastlain KA et al (2005) Selective alterations of gene expression in mice induced by MPTP. Synapse 55:45\u201351. doi: 10.1002\/syn.20089","journal-title":"Synapse"},{"key":"2052_CR118","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drugalcdep.2014.10.027","volume":"146","author":"K Curtin","year":"2015","unstructured":"Curtin K, Fleckenstein AE, Robison RJ et al (2015) Methamphetamine\/amphetamine abuse and risk of Parkinson\u2019s disease in Utah: a population-based assessment. Drug Alcohol Depend 146:30\u201338. doi: 10.1016\/j.drugalcdep.2014.10.027","journal-title":"Drug Alcohol Depend"},{"key":"2052_CR119","doi-asserted-by":"publisher","first-page":"308052","DOI":"10.1155\/2013\/308052","volume":"2013","author":"N Granado","year":"2013","unstructured":"Granado N, Ares-Santos S, Moratalla R (2013) Methamphetamine and Parkinson\u2019s disease. Parkinsons Dis 2013:308052. doi: 10.1155\/2013\/308052","journal-title":"Parkinsons Dis"},{"key":"2052_CR120","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1001\/jamapsychiatry.2014.399","volume":"71","author":"M Kohno","year":"2014","unstructured":"Kohno M, Morales AM, Ghahremani DG et al (2014) Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependence. JAMA Psychiatry 71:812\u2013820. doi: 10.1001\/jamapsychiatry.2014.399","journal-title":"JAMA Psychiatry"},{"key":"2052_CR121","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/npp.2013.307","volume":"39","author":"S Ares-Santos","year":"2014","unstructured":"Ares-Santos S, Granado N, Espadas I et al (2014) Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining. Neuropsychopharmacology 39:1066\u20131080. doi: 10.1038\/npp.2013.307","journal-title":"Neuropsychopharmacology"},{"key":"2052_CR122","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1523\/JNEUROSCI.14-04-02260.1994","volume":"14","author":"JF Cubells","year":"1994","unstructured":"Cubells JF, Rayport S, Rajendran G, Sulzer D (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci 14:2260\u20132271","journal-title":"J Neurosci"},{"key":"2052_CR123","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1196\/annals.1316.021","volume":"1025","author":"F Fornai","year":"2004","unstructured":"Fornai F, Lenzi P, Gesi M et al (2004) Similarities between methamphetamine toxicity and proteasome inhibition. Ann N Y Acad Sci 1025:162\u2013170. doi: 10.1196\/annals.1316.021","journal-title":"Ann N Y Acad Sci"},{"key":"2052_CR124","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/bmj.331.7515.476","volume":"331","author":"B Roehr","year":"2005","unstructured":"Roehr B (2005) Half a million Americans use methamphetamine every week. BMJ 331:476. doi: 10.1136\/bmj.331.7515.476","journal-title":"BMJ"},{"key":"2052_CR125","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.1471-4159.2010.07147.x","volume":"116","author":"A Moszczynska","year":"2011","unstructured":"Moszczynska A, Yamamoto BK (2011) Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo. J Neurochem 116:1005\u20131017. doi: 10.1111\/j.1471-4159.2010.07147.x","journal-title":"J Neurochem"},{"key":"2052_CR126","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.expneurol.2013.01.001","volume":"247","author":"B Liu","year":"2013","unstructured":"Liu B, Traini R, Killinger B et al (2013) Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity. Exp Neurol 247:359\u2013372. doi: 10.1016\/j.expneurol.2013.01.001","journal-title":"Exp Neurol"},{"key":"2052_CR127","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","volume":"119","author":"CM Tanner","year":"2011","unstructured":"Tanner CM, Kamel F, Ross GW et al (2011) Rotenone, paraquat, and Parkinson\u2019s disease. Environ Health Perspect 119:866\u2013872. doi: 10.1289\/ehp.1002839","journal-title":"Environ Health Perspect"},{"key":"2052_CR128","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.tips.2008.03.007","volume":"29","author":"JM Hatcher","year":"2008","unstructured":"Hatcher JM, Pennell KD, Miller GW (2008) Parkinson\u2019s disease and pesticides: a toxicological perspective. Trends Pharmacol Sci 29:322\u2013329. doi: 10.1016\/j.tips.2008.03.007","journal-title":"Trends Pharmacol Sci"},{"key":"2052_CR129","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G et al (2000) Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci 3:1301\u20131306. doi: 10.1038\/81834","journal-title":"Nat Neurosci"},{"key":"2052_CR130","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","volume":"23","author":"TB Sherer","year":"2003","unstructured":"Sherer TB, Betarbet R, Testa CM et al (2003) Mechanism of toxicity in rotenone models of Parkinson\u2019s disease. J Neurosci 23:10756\u201310764","journal-title":"J Neurosci"},{"key":"2052_CR131","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1523\/JNEUROSCI.22-03-00782.2002","volume":"22","author":"H-M Gao","year":"2002","unstructured":"Gao H-M, Hong J-S, Zhang W, Liu B (2002) Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 22:782\u2013790","journal-title":"J Neurosci"},{"key":"2052_CR132","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3181\/00379727-136-35352","volume":"136","author":"WG Bergen","year":"1971","unstructured":"Bergen WG (1971) The in vitro effect of dieldrin on respiration of rat liver mitochondria. Proc Soc Exp Biol Med 136:732\u2013735","journal-title":"Proc Soc Exp Biol Med"},{"key":"2052_CR133","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1046\/j.1471-4159.2003.01525.x","volume":"84","author":"J Zhang","year":"2003","unstructured":"Zhang J, Fitsanakis VA, Gu G et al (2003) Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction. J Neurochem 84:336\u2013346","journal-title":"J Neurochem"},{"key":"2052_CR134","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.freeradbiomed.2008.02.008","volume":"44","author":"DA Drechsel","year":"2008","unstructured":"Drechsel DA, Patel M (2008) Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson\u2019s disease. Free Radic Biol Med 44:1873\u20131886. doi: 10.1016\/j.freeradbiomed.2008.02.008","journal-title":"Free Radic Biol Med"},{"key":"2052_CR135","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/009841000156907","volume":"59","author":"FM Corrigan","year":"2000","unstructured":"Corrigan FM, Wienburg CL, Shore RF et al (2000) Organochlorine insecticides in substantia nigra in Parkinson\u2019s disease. J Toxicol Environ Health A 59:229\u2013234","journal-title":"J Toxicol Environ Health A"},{"key":"2052_CR136","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/ana.410360119","volume":"36","author":"L Fleming","year":"1994","unstructured":"Fleming L, Mann JB, Bean J et al (1994) Parkinson\u2019s disease and brain levels of organochlorine pesticides. Ann Neurol 36:100\u2013103. doi: 10.1002\/ana.410360119","journal-title":"Ann Neurol"},{"key":"2052_CR137","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1006\/exnr.1997.6770","volume":"150","author":"J Sanchez-Ramos","year":"1998","unstructured":"Sanchez-Ramos J, Facca A, Basit A, Song S (1998) Toxicity of dieldrin for dopaminergic neurons in mesencephalic cultures. Exp Neurol 150:263\u2013271. doi: 10.1006\/exnr.1997.6770","journal-title":"Exp Neurol"},{"key":"2052_CR138","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1756-6606-1-12","volume":"1","author":"AG Kanthasamy","year":"2008","unstructured":"Kanthasamy AG, Kitazawa M, Yang Y et al (2008) Environmental neurotoxin dieldrin induces apoptosis via caspase-3-dependent proteolytic activation of protein kinase C delta (PKCdelta): implications for neurodegeneration in Parkinson\u2019s disease. Mol Brain 1:12. doi: 10.1186\/1756-6606-1-12","journal-title":"Mol Brain"},{"key":"2052_CR139","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/S0891-5849(01)00726-2","volume":"31","author":"M Kitazawa","year":"2001","unstructured":"Kitazawa M, Anantharam V, Kanthasamy AG (2001) Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells. Free Radic Biol Med 31:1473\u20131485","journal-title":"Free Radic Biol Med"},{"key":"2052_CR140","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0041-008X(80)90383-X","volume":"53","author":"GH Heinz","year":"1980","unstructured":"Heinz GH, Hill EF, Contrera JF (1980) Dopamine and norepinephrine depletion in ring doves fed DDE, dieldrin, and Aroclor 1254. Toxicol Appl Pharmacol 53:75\u201382","journal-title":"Toxicol Appl Pharmacol"},{"key":"2052_CR141","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1096\/fj.06-5864fje","volume":"20","author":"JR Richardson","year":"2006","unstructured":"Richardson JR, Caudle WM, Wang M et al (2006) Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson\u2019s disease. FASEB J 20:1695\u20131697. doi: 10.1096\/fj.06-5864fje","journal-title":"FASEB J"},{"key":"2052_CR142","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.expneurol.2006.12.020","volume":"204","author":"JM Hatcher","year":"2007","unstructured":"Hatcher JM, Richardson JR, Guillot TS et al (2007) Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Exp Neurol 204:619\u2013630. doi: 10.1016\/j.expneurol.2006.12.020","journal-title":"Exp Neurol"},{"key":"2052_CR143","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1124\/jpet.105.084632","volume":"315","author":"F Sun","year":"2005","unstructured":"Sun F, Anantharam V, Latchoumycandane C et al (2005) Dieldrin induces ubiquitin\u2013proteasome dysfunction in alpha-synuclein overexpressing dopaminergic neuronal cells and enhances susceptibility to apoptotic cell death. J Pharmacol Exp Ther 315:69\u201379. doi: 10.1124\/jpet.105.084632","journal-title":"J Pharmacol Exp Ther"},{"key":"2052_CR144","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","volume":"78","author":"CA Haaxma","year":"2007","unstructured":"Haaxma CA, Bloem BR, Borm GF et al (2007) Gender differences in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatr 78:819\u2013824. doi: 10.1136\/jnnp.2006.103788","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"2052_CR145","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1161\/01.CIR.98.25.2883","volume":"98","author":"I Spyridopoulos","year":"1998","unstructured":"Spyridopoulos I, Principe N, Krasinski KL et al (1998) Restoration of E2F expression rescues vascular endothelial cells from tumor necrosis factor-alpha-induced apoptosis. Circulation 98:2883\u20132890","journal-title":"Circulation"},{"key":"2052_CR146","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/0892-0362(96)00086-4","volume":"18","author":"DE Dluzen","year":"1996","unstructured":"Dluzen DE, McDermott JL, Liu B (1996) Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57\/B1 mice. Neurotoxicol Teratol 18:603\u2013606","journal-title":"Neurotoxicol Teratol"},{"key":"2052_CR147","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/(SICI)1097-4695(199609)31:1<77::AID-NEU7>3.0.CO;2-C","volume":"31","author":"R Miranda","year":"1996","unstructured":"Miranda R, Sohrabji F, Singh M, Toran-Allerand D (1996) Nerve growth factor (NGF) regulation of estrogen receptors in explant cultures of the developing forebrain. J Neurobiol 31:77\u201387. doi: 10.1002\/(SICI)1097-4695(199609)31:1<77::AID-NEU7>3.0.CO;2-C","journal-title":"J Neurobiol"},{"key":"2052_CR148","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1523\/JNEUROSCI.19-01-00010.1999","volume":"19","author":"JH Son","year":"1999","unstructured":"Son JH, Chun HS, Joh TH et al (1999) Neuroprotection and neuronal differentiation studies using substantia nigra dopaminergic cells derived from transgenic mouse embryos. J Neurosci 19:10\u201320","journal-title":"J Neurosci"},{"key":"2052_CR149","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.parkreldis.2014.08.003","volume":"20","author":"NM Gatto","year":"2014","unstructured":"Gatto NM, Deapen D, Stoyanoff S et al (2014) Lifetime exposure to estrogens and Parkinson\u2019s disease in California teachers. Parkinsonism Relat Disord 20:1149\u20131156. doi: 10.1016\/j.parkreldis.2014.08.003","journal-title":"Parkinsonism Relat Disord"},{"key":"2052_CR150","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1212\/WNL.52.1.115","volume":"52","author":"JM Gorell","year":"1999","unstructured":"Gorell JM, Rybicki BA, Johnson CC, Peterson EL (1999) Smoking and Parkinson\u2019s disease: a dose-response relationship. Neurology 52:115\u2013119","journal-title":"Neurology"},{"key":"2052_CR151","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1212\/WNL.30.8.839","volume":"30","author":"RJ Baumann","year":"1980","unstructured":"Baumann RJ, Jameson HD, McKean HE et al (1980) Cigarette smoking and Parkinson disease: 1. Comparison of cases with matched neighbors. Neurology 30:839\u2013843","journal-title":"Neurology"},{"key":"2052_CR152","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/0306-4522(93)90039-I","volume":"57","author":"AM Janson","year":"1993","unstructured":"Janson AM, M\u00f8ller A (1993) Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: an analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat. Neuroscience 57:931\u2013941","journal-title":"Neuroscience"},{"key":"2052_CR153","first-page":"33","volume":"51","author":"T Mitsuoka","year":"2002","unstructured":"Mitsuoka T, Kaseda Y, Yamashita H et al (2002) Effects of nicotine chewing gum on UPDRS score and P300 in early-onset parkinsonism. Hiroshima J Med Sci 51:33\u201339","journal-title":"Hiroshima J Med Sci"},{"key":"2052_CR154","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/BF02245195","volume":"117","author":"P Clemens","year":"1995","unstructured":"Clemens P, Baron JA, Coffey D, Reeves A (1995) The short-term effect of nicotine chewing gum in patients with Parkinson\u2019s disease. Psychopharmacology (Berl) 117:253\u2013256","journal-title":"Psychopharmacology (Berl)"},{"key":"2052_CR155","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/1531-8257(199911)14:6<1011::AID-MDS1016>3.0.CO;2-F","volume":"14","author":"G Ebersbach","year":"1999","unstructured":"Ebersbach G, St\u00f6ck M, M\u00fcller J et al (1999) Worsening of motor performance in patients with Parkinson\u2019s disease following transdermal nicotine administration. Mov Disord 14:1011\u20131013","journal-title":"Mov Disord"},{"key":"2052_CR156","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/0028-3908(86)90208-X","volume":"25","author":"H Watanabe","year":"1986","unstructured":"Watanabe H, Uramoto H (1986) Caffeine mimics dopamine receptor agonists without stimulation of dopamine receptors. Neuropharmacology 25:577\u2013581","journal-title":"Neuropharmacology"},{"key":"2052_CR157","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.neulet.2007.12.034","volume":"432","author":"K Nakaso","year":"2008","unstructured":"Nakaso K, Ito S, Nakashima K (2008) Caffeine activates the PI3K\/Akt pathway and prevents apoptotic cell death in a Parkinson\u2019s disease model of SH-SY5Y cells. Neurosci Lett 432:146\u2013150. doi: 10.1016\/j.neulet.2007.12.034","journal-title":"Neurosci Lett"},{"key":"2052_CR158","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/ana.1052","volume":"50","author":"A Ascherio","year":"2001","unstructured":"Ascherio A, Zhang SM, Hern\u00e1n MA et al (2001) Prospective study of caffeine consumption and risk of Parkinson\u2019s disease in men and women. Ann Neurol 50:56\u201363","journal-title":"Ann Neurol"},{"key":"2052_CR159","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1212\/WNL.55.9.1350","volume":"55","author":"MD Benedetti","year":"2000","unstructured":"Benedetti MD, Bower JH, Maraganore DM et al (2000) Smoking, alcohol, and coffee consumption preceding Parkinson\u2019s disease: a case-control study. Neurology 55:1350\u20131358","journal-title":"Neurology"},{"key":"2052_CR160","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/j.1471-4159.1984.tb12834.x","volume":"43","author":"TL Perry","year":"1984","unstructured":"Perry TL, Yong VW, Ito M et al (1984) Nigrostriatal dopaminergic neurons remain undamaged in rats given high doses of L-DOPA and carbidopa chronically. J Neurochem 43:990\u2013993","journal-title":"J Neurochem"},{"key":"2052_CR161","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1056\/NEJM196902132800701","volume":"280","author":"GC Cotzias","year":"1969","unstructured":"Cotzias GC, Papavasiliou PS, Gellene R (1969) Modification of Parkinsonism\u2014chronic treatment with L-dopa. N Engl J Med 280:337\u2013345. doi: 10.1056\/NEJM196902132800701","journal-title":"N Engl J Med"},{"key":"2052_CR162","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/pgmj.2006.054759","volume":"83","author":"B Thanvi","year":"2007","unstructured":"Thanvi B, Lo N, Robinson T (2007) Levodopa-induced dyskinesia in Parkinson\u2019s disease: clinical features, pathogenesis, prevention and treatment. Postgrad Med J 83:384\u2013388. doi: 10.1136\/pgmj.2006.054759","journal-title":"Postgrad Med J"},{"key":"2052_CR163","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.4103\/1673-5374.160094","volume":"10","author":"A-S Moldovan","year":"2015","unstructured":"Moldovan A-S, Groiss SJ, Elben S et al (2015) The treatment of Parkinson\u2019s disease with deep brain stimulation: current issues. Neural Regen Res 10:1018\u20131022. doi: 10.4103\/1673-5374.160094","journal-title":"Neural Regen Res"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-016-2052-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-016-2052-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-016-2052-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T17:42:16Z","timestamp":1749577336000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-016-2052-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,9]]},"references-count":163,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["2052"],"URL":"https:\/\/doi.org\/10.1007\/s11064-016-2052-4","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"type":"print","value":"0364-3190"},{"type":"electronic","value":"1573-6903"}],"subject":[],"published":{"date-parts":[[2016,9,9]]},"assertion":[{"value":"29 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}